China NT Pharma Group Company Limited (1011.HK)

HKD 0.41

(-7.87%)

Inventory Summary of China NT Pharma Group Company Limited

China NT Pharma Group Company Limited's latest annual inventory in 2023 was - CNY , down -100.0% from previous year.
China NT Pharma Group Company Limited's latest quarterly inventory in 2024 Q2 was - CNY , down 0.0% from previous quarter.
China NT Pharma Group Company Limited reported annual inventory of 10.31 Million CNY in 2022, down -67.76% from previous year.
China NT Pharma Group Company Limited reported annual inventory of 32 Million CNY in 2021, up 17.29% from previous year.
China NT Pharma Group Company Limited reported quarterly inventory of 12.32 Million CNY for 2023 Q2, down 0.0% from previous quarter.
China NT Pharma Group Company Limited reported quarterly inventory of - CNY for 2023 FY, down -100.0% from previous quarter.

Annual Inventory Chart of China NT Pharma Group Company Limited (2023 - 2010)

Historical Annual Inventory of China NT Pharma Group Company Limited (2023 - 2010)

Year	Inventory	Inventory Growth
2023	- CNY	-100.0%
2022	10.31 Million CNY	-67.76%
2021	32 Million CNY	17.29%
2020	27.28 Million CNY	-20.82%
2019	34.46 Million CNY	-23.36%
2018	44.96 Million CNY	-31.16%
2017	65.31 Million CNY	-60.9%
2016	167.06 Million CNY	-4.45%
2015	174.83 Million CNY	107.54%
2014	84.24 Million CNY	-36.38%
2013	132.4 Million CNY	-45.49%
2012	242.92 Million CNY	-31.7%
2011	355.67 Million CNY	-32.52%
2010	527.05 Million CNY	0.0%

Year	Inventory	Inventory Growth
2024 Q2	- CNY	0.0%
2023 Q2	12.32 Million CNY	0.0%
2023 FY	- CNY	-100.0%
2023 Q4	- CNY	0.0%
2022 Q2	23.2 Million CNY	0.0%
2022 FY	10.31 Million CNY	-67.76%
2022 Q4	10.31 Million CNY	0.0%
2021 Q2	23.27 Million CNY	0.0%
2021 Q4	32 Million CNY	0.0%
2021 FY	32 Million CNY	17.29%
2020 FY	27.28 Million CNY	-20.82%
2020 Q2	33.62 Million CNY	0.0%
2020 Q4	27.28 Million CNY	0.0%
2019 Q2	52.65 Million CNY	0.0%
2019 FY	34.46 Million CNY	-23.36%
2019 Q4	34.46 Million CNY	0.0%
2018 Q2	63.86 Million CNY	0.0%
2018 FY	44.96 Million CNY	-31.16%
2018 Q4	44.96 Million CNY	0.0%
2017 FY	65.31 Million CNY	-60.9%
2017 Q2	103.06 Million CNY	0.0%
2017 Q4	65.31 Million CNY	0.0%
2016 FY	167.06 Million CNY	-4.45%
2016 Q4	167.06 Million CNY	0.0%
2016 Q2	131.22 Million CNY	0.0%
2015 Q4	174.83 Million CNY	0.0%
2015 FY	174.83 Million CNY	107.54%
2015 Q2	73.04 Million CNY	0.0%
2014 Q4	84.24 Million CNY	0.0%
2014 Q2	84.78 Million CNY	0.0%
2014 FY	84.24 Million CNY	-36.38%
2013 Q4	132.4 Million CNY	0.0%
2013 FY	132.4 Million CNY	-45.49%
2013 Q2	148.43 Million CNY	0.0%
2012 Q2	340.07 Million CNY	0.0%
2012 Q4	242.92 Million CNY	0.0%
2012 FY	242.92 Million CNY	-31.7%
2011 Q4	355.67 Million CNY	0.0%
2011 Q2	568.16 Million CNY	0.0%
2011 FY	355.67 Million CNY	-32.52%
2010 Q4	527.05 Million CNY	0.0%
2010 FY	527.05 Million CNY	0.0%

Peer Inventory Comparison of China NT Pharma Group Company Limited

Name	Inventory	Inventory Difference
Pak Fah Yeow International Limited	12.19 Million HKD	100.0%
Grand Pharmaceutical Group Limited	1.38 Billion HKD	100.0%
Extrawell Pharmaceutical Holdings Limited	7.26 Million HKD	100.0%
Wai Yuen Tong Medicine Holdings Limited	308.09 Million HKD	100.0%
Qianhai Health Holdings Limited	431.78 Million HKD	100.0%
Lee's Pharmaceutical Holdings Limited	298.1 Million HKD	100.0%
Essex Bio-Technology Limited	62.82 Million HKD	100.0%
Tongfang Kontafarma Holdings Limited	98.26 Million HKD	100.0%
PuraPharm Corporation Limited	175.59 Million HKD	100.0%
SSY Group Limited	1.08 Billion HKD	100.0%
JBM (Healthcare) Limited	91.58 Million HKD	100.0%
Jacobson Pharma Corporation Limited	317.85 Million HKD	100.0%
China Resources Pharmaceutical Group Limited	35.09 Billion HKD	100.0%